For model development, genetic data will involve genetic testing of high penetrance genes associated with hereditary breast and ovarian cancer, BRCA1 and BRCA2, as well as lower penetrance genes associated with ovarian cancer susceptibility, BRIP1, RAD51C and RAD51D [9–11]. This evidence concerns the gene BRIP1 and ovarian cancer.